Discover
NBP
NovaBridge Biosciences
1.84
26 x 1.83
10 x 1.84
bid
ask
+
0.07
3.95%
01:34 PM
timesize
| Ytd | -53.77% | |
| 1y | -52.70% |
1.77
day range
1.84
1.46
52 week range
6.79
| Open | 1.77 | Prev Close | 1.77 | Low | 1.77 | High | 1.84 | Mkt Cap | 212.09M |
| Vol | 194.40K | Avg Vol | 589.75K | EPS | -0.39 | P/E | -4.72 | Forward P/E | N/A |
| Beta | 1.47 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-14 | 50-d Avg | 1.73 | 200-d Avg | 2.94 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 72.90M | ||
| Research and Development Expense | 55.66M | ||
| Selling, General and Administrative Expense | 17.24M | ||
| Operating Income | -72.90M | ||
| Net Income | -30.79M | ||
| Net Income Common Stock | -30.79M | ||
| Net Income Common Stock (USD) | -30.79M | ||
| Consolidated Income | -72.86M | ||
| Net Income to Non-Controlling Interests | -42.07M | ||
| Earnings per Basic Share | -0.30 | ||
| Earnings per Basic Share (USD) | -0.30 | ||
| Earnings per Diluted Share | -0.30 | ||
| Earning Before Interest & Taxes (EBIT) | -30.79M | ||
| Earning Before Interest & Taxes (USD) | -30.79M | ||
| Weighted Average Shares | 220.26M | ||
| Weighted Average Shares Diluted | 220.26M | ||
| Balance Sheet | |||
| Cash and Equivalents | 210.63M | ||
| Cash and Equivalents (USD) | 210.63M | ||
| Investments | 37.45M | ||
| Investments Current | 210.00K | ||
| Investments Non-Current | 37.24M | ||
| Trade and Non-Trade Receivables | 6.68M | ||
| Current Assets | 217.52M | ||
| Property, Plant & Equipment Net | 2.95M | ||
| Total Assets | 260.52M | ||
| Debt Current | 891.00K | ||
| Total Debt | 3.07M | ||
| Current Liabilities | 26.89M | ||
| Debt Non-Current | 2.18M | ||
| Total Liabilities | 29.58M | ||
| Accumulated Retained Earnings (Deficit) | -1.33B | ||
| Accumulated Other Comprehensive Income | 41.55M | ||
| Shareholders Equity | 230.94M | ||
| Shareholders Equity (USD) | 230.94M | ||
| Assets Non-Current | 43.00M | ||
| Total Debt (USD) | 3.07M | ||
| Liabilities Non-Current | 2.69M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 216.00K | ||
| Net Cash Flow from Financing | -3.02M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -17.43M | ||
| Issuance (Purchase) of Equity Shares | 200.00K | ||
| Issuance (Repayment) of Debt Securities | 966.00K | ||
| Net Cash Flow from Operations | -14.60M | ||
| Effect of Exchange Rate Changes on Cash | 187.00K | ||
| Share Based Compensation | 3.95M | ||